BioCentury | Aug 9, 2010
Clinical News
FTA Bioscience, Pure Bioscience preclinical data
...silver dihydrogen citrate for 7 days produced significant mycological and clinical improvements vs. untreated controls. FTA Bioscience...
...exclusive, worldwide rights to the electrolytically generated source of stabilized ionic silver from Pure Bioscience. FTA Bioscience...
...INDs for multiple silver dihydrogen citrate-based products to treat foot and nail funguses next year. FTA Bioscience LLC...
...exclusive, worldwide rights to the electrolytically generated source of stabilized ionic silver from Pure Bioscience. FTA Bioscience...
...INDs for multiple silver dihydrogen citrate-based products to treat foot and nail funguses next year. FTA Bioscience LLC...